EXCEED THE SPACEPROVIDED.This is a resubmission of a competitive renewal application for the General Clinical Research Center (GCRC) at Beth Israel Deaconess Medical Center (BIDMC) and our two satellites at the Joslin Diabetes Center and the Forsyth Institute. We ask for continued support to extend our successful 30-year history.The proposal provides an overview of the rich and diverse research conducted by investigators at ourGCRC, documenting the active collaborations and sharing of resources among various disciplines anddepartments. Translational research efforts, converting insights from the laboratory into the safest, best-designed and controlled clinical trials to address human diseases that have major health care impact, continue to be the primary goal of our GCRC. In addition, we remain committed to the education of young investigators and future leaders in clinical research through a growing number of teaching and training programs in which the GCRC plays a crucial role.We have carefully considered the input from the reviewers of our initial submission and have followed theirvarious suggestions as detailed in our Introduction (page 485). We have changed some of the mainpresentations to provide a better overview of the outstanding science being conducted at our GCRC, andour Institutional Review Board has implemented a number of changes to the review and approval processof new studies. This will allow us to continue to assure the safest possible environment for our researchsubjects.Specific areas of investigation that are highlighted in this application include: 1) pathophysiology ofobstructive sleep apnea, 2) plasticity of the brain following loss of vision, 3) decitabine alteration of geneexpression profile of tumor cells, potentially increasing their sensitivity to dacarbazine, 4) role of blood pressure on vasoregulation and cerebral perfusion in elderly patients after stroke, 5) potential use of leptin in the treatment of amenorrhea, infertility, and bone loss in women with hypothalamic dysfunction, 6) role ofthe oral microbiota in refractory and treatable periodontitis, and 7) the role of insulin in regulating ft-cellfunction in healthy and insulin resistant populations.

National Institute of Health (NIH)
National Center for Research Resources (NCRR)
General Clinical Research Centers Program (M01)
Project #
Application #
Study Section
National Center for Research Resources Initial Review Group (RIRG)
Program Officer
Talbot, Bernard
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
Beth Israel Deaconess Medical Center
United States
Zip Code
Nowak, Kristen L; You, Zhiying; Gitomer, Berenice et al. (2018) Overweight and Obesity Are Predictors of Progression in Early Autosomal Dominant Polycystic Kidney Disease. J Am Soc Nephrol 29:571-578
Chung, Chen-Chih; Pimentel Maldonado, Daniela A; Jor'dan, Azizah J et al. (2018) Lower cerebral vasoreactivity as a predictor of gait speed decline in type 2 diabetes mellitus. J Neurol 265:2267-2276
Kline, Emily R; Seidman, Larry J; Cornblatt, Barbara A et al. (2018) Depression and clinical high-risk states: Baseline presentation of depressed vs. non-depressed participants in the NAPLS-2 cohort. Schizophr Res 192:357-363
Simpson, Norah S; Scott-Sutherland, Jennifer; Gautam, Shiva et al. (2018) Chronic exposure to insufficient sleep alters processes of pain habituation and sensitization. Pain 159:33-40
Dai, Weiying; Duan, Wenna; Alfaro, Freddy J et al. (2017) The resting perfusion pattern associates with functional decline in type 2 diabetes. Neurobiol Aging 60:192-202
Brosnahan, Godela M; Abebe, Kaleab Z; Rahbari-Oskoui, Frederic F et al. (2017) Effect of Statin Therapy on the Progression of Autosomal Dominant Polycystic Kidney Disease. A Secondary Analysis of the HALT PKD Trials. Curr Hypertens Rev 13:109-120
Torres, Vicente E; Abebe, Kaleab Z; Schrier, Robert W et al. (2017) Dietary salt restriction is beneficial to the management of autosomal dominant polycystic kidney disease. Kidney Int 91:493-500
Irazabal, María V; Abebe, Kaleab Z; Bae, Kyongtae Ty et al. (2017) Prognostic enrichment design in clinical trials for autosomal dominant polycystic kidney disease: the HALT-PKD clinical trial. Nephrol Dial Transplant 32:1857-1865
Seidman, Larry J; Shapiro, Daniel I; Stone, William S et al. (2016) Association of Neurocognition With Transition to Psychosis: Baseline Functioning in the Second Phase of the North American Prodrome Longitudinal Study. JAMA Psychiatry 73:1239-1248
Thermenos, Heidi W; Juelich, Richard J; DiChiara, Samantha R et al. (2016) Hyperactivity of caudate, parahippocampal, and prefrontal regions during working memory in never-medicated persons at clinical high-risk for psychosis. Schizophr Res 173:1-12

Showing the most recent 10 out of 642 publications